Market News

Biogen (BIIB) Shareholder Sands Capital Management Has Trimmed Position as Valuation Declined; South State (SSB) Holder South State Raised Stake

South State Corp increased its stake in South State Corporation (SSB) by 7.34% based on its latest 2017Q3 regulatory filing with the SEC. South State Corp bought 4,753 shares as the company’s stock declined 7.90% while stock markets rallied. The institutional investor held 69,465 shares of the major banks company at the end of 2017Q3, valued at $6.26M, up from 64,712 at the end of the previous reported quarter. South State Corp who had been investing in South State Corporation for a number of months, seems to be bullish on the $3.24 billion market cap company. The stock increased 1.26% or $1.1 during the last trading session, reaching $88.7. About 66,762 shares traded. South State Corporation (NASDAQ:SSB) has risen 19.60% since February 24, 2017 and is uptrending. It has outperformed by 2.90% the S&P500.

Sands Capital Management Llc decreased its stake in Biogen Inc (BIIB) by 5.55% based on its latest 2017Q3 regulatory filing with the SEC. Sands Capital Management Llc sold 70,991 shares as the company’s stock declined 13.45% while stock markets rallied. The institutional investor held 1.21 million shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $377.99M, down from 1.28M at the end of the previous reported quarter. Sands Capital Management Llc who had been investing in Biogen Inc for a number of months, seems to be less bullish one the $61.94 billion market cap company. The stock increased 2.80% or $7.97 during the last trading session, reaching $292.78. About 2.54M shares traded or 80.50% up from the average. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 24, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

South State Corp, which manages about $892.42M US Long portfolio, decreased its stake in Devon Energy Corporation New (NYSE:DVN) by 25,345 shares to 91,542 shares, valued at $3.36 million in 2017Q3, according to the filing. It also reduced its holding in Goldman Sachs Group Inc Com (NYSE:GS) by 4,927 shares in the quarter, leaving it with 33,906 shares, and cut its stake in Citrix Sys Inc (NASDAQ:CTXS).

Among 8 analysts covering South State Corp (NASDAQ:SSB), 4 have Buy rating, 0 Sell and 4 Hold. Therefore 50% are positive. South State Corp had 26 analyst reports since July 28, 2015 according to SRatingsIntel. Wood upgraded South State Corporation (NASDAQ:SSB) on Tuesday, July 25 to “Outperform” rating. SunTrust maintained South State Corporation (NASDAQ:SSB) rating on Monday, January 8. SunTrust has “Buy” rating and $112.0 target. The stock of South State Corporation (NASDAQ:SSB) earned “Hold” rating by Brean Capital on Monday, October 30. Keefe Bruyette & Woods downgraded the shares of SSB in report on Tuesday, November 29 to “Mkt Perform” rating. The company was maintained on Friday, December 1 by Brean Capital. The stock has “Hold” rating by Brean Capital on Wednesday, August 2. The stock of South State Corporation (NASDAQ:SSB) earned “Hold” rating by Brean Capital on Monday, February 5. As per Monday, September 21, the company rating was initiated by Piper Jaffray. The firm has “Buy” rating by SunTrust given on Thursday, October 26. The company was maintained on Tuesday, November 28 by SunTrust.

Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on April, 24. They expect $5.94 earnings per share, up 14.23% or $0.74 from last year’s $5.2 per share. BIIB’s profit will be $1.26B for 12.32 P/E if the $5.94 EPS becomes a reality. After $5.26 actual earnings per share reported by Biogen Inc. for the previous quarter, Wall Street now forecasts 12.93% EPS growth.

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 9 Hold. Therefore 73% are positive. Biogen Idec Inc. had 113 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Market Perform” rating by Leerink Swann on Thursday, March 16. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Neutral” rating by UBS on Wednesday, July 26. The firm earned “Outperform” rating on Friday, December 4 by Wells Fargo. The rating was reinitiated by PiperJaffray on Monday, October 23 with “Overweight”. H.C. Wainwright initiated it with “Buy” rating and $380 target in Tuesday, August 11 report. The firm has “Hold” rating by Robert W. Baird given on Monday, October 30. The rating was maintained by Canaccord Genuity with “Hold” on Wednesday, January 24. The firm earned “Outperform” rating on Wednesday, June 29 by Bernstein. Stifel Nicolaus upgraded Biogen Inc. (NASDAQ:BIIB) on Tuesday, October 17 to “Buy” rating. Standpoint Research initiated the stock with “Buy” rating in Thursday, January 7 report.

Since January 9, 2018, it had 0 insider purchases, and 3 insider sales for $2.53 million activity. The insider PANGIA ROBERT W sold $1.92 million.

Sands Capital Management Llc, which manages about $42.07B and $33.38 billion US Long portfolio, upped its stake in Costar Group Inc (NASDAQ:CSGP) by 663,189 shares to 1.55M shares, valued at $415.13M in 2017Q3, according to the filing. It also increased its holding in Servicenow Inc (NYSE:NOW) by 1.39M shares in the quarter, for a total of 7.64 million shares, and has risen its stake in Ishares Tr (INDA).

Leave a Reply

Your email address will not be published. Required fields are marked *